## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -0.1% below STRENGTH zone (3.0-6.0%); PEG 3.39 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Night Squared LP Purchases Shares of 236,242 Hormel Foods Corporation $HRL**
- Source: MarketBeat | 20251210T125348 | Somewhat-Bullish | Relevance: 100%
-  Night Squared LP acquired a new position in Hormel Foods Corporation, purchasing 236,242 shares valued at approximately $7.146 million, making it their 8th biggest holding. Several other hedge funds have also adjusted their positions in Hormel Foods, and analysts have set various price targets and ratings for the stock. Hormel Foods recently delivered quarterly earnings topping estimates and increased its quarterly dividend.

**2. Meating a Milestone**
- Source: Hormel Foods | 20251210T190747 | Bullish | Relevance: 99%
-  Hormel Foods celebrates a significant milestone with 100 million SPAM® musubi units sold at FamilyMart in Japan since their 2021 introduction. Initially a limited-time offer, SPAM® musubi is now available in over 16,000 stores nationwide, highlighting the success of local adaptation and consumer understanding. This achievement underscores the SPAM® brand's global cultural impact and its effective expansion strategy in international markets.

**3. ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation – HRL**
- Source: GlobeNewswire | 20251209T220841 | Neutral | Relevance: 99%
- The Rosen Law Firm has announced an investigation into potential securities claims against Hormel Foods Corporation (NYSE: HRL) after allegations of materially misleading business information were issued to the public. This follows a Wall Street Journal article stating Hormel cut its forecast due to price pressures, bird flu, and a fire, accompanied by a 9.1% stock drop. Investors who purchased Hormel securities are encouraged to contact Rosen Law Firm to inquire about joining a potential class action lawsuit for compensation.

**4. Hormel Foods Named to Fast Company’s 2025 Brands That Matter List**
- Source: Perishable News | 20251209T180113 | Bullish | Relevance: 98%
-  Hormel Foods Corporation has been recognized on Fast Company’s 2025 Brands That Matter list for its impactful multi-brand, multi-channel marketing campaigns. The company's "Here for the Snacks" Big Game campaign successfully connected with consumers by positioning snacking as a key part of the event, showcasing the creativity of its marketing team. This honor highlights Hormel Foods' ability to engage audiences meaningfully and achieve real business impact.

**5. California Public Employees Retirement System Has $32.11 Million Holdings in Hormel Foods Corporation $HRL**
- Source: MarketBeat | 20251211T093820 | Neutral | Relevance: 98%
-  The California Public Employees Retirement System reduced its stake in Hormel Foods Corporation (NYSE:HRL) by 17.4% in the second quarter, now holding 1,061,354 shares worth $32.11 million. Despite this reduction, other institutional investors have increased their holdings. Hormel Foods recently reported quarterly earnings that topped analyst estimates and announced an increase in its quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Valuation risk: PEG 3.4x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 13.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.39 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.18). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.0B |
| Beta | 0.33 |
| 52W Range | $21.03 - $33.32 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.39 |
| Forward P/E | 15.2 |
| Current P/E | 16.4 |
| YoY Growth | 8.0% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 2.8% to -0.1% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >3.0% for momentum thesis). Below SMA200 (0.86x), long-term trend not supportive. RSI neutral at 57.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.07% (CS: 38) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | 0.12 | Bullish |
| vs SMA20 | 1.026x | Above |
| vs SMA50 | 1.025x | Above |
| vs SMA200 | 0.861x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.71
- **Stop Loss:** $22.65 (4.5% risk)
- **Target:** $24.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1301
- **Position Value:** $30,846.71
- **Portfolio %:** 30.85%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*